Can IgG positivity alone prove active Lyme arthritis?

Lyme serology is most informative when interpreted in the context of the current joint syndrome, rather than as a direct marker of ongoing infection. This is particularly relevant after prior Lyme disease, when antibodies may substantially outlast active infection.

Serology and clinical evidence

• Borrelia-specific IgG can persist long after treated infection: in follow-up 10–20 years after Lyme disease, IgG remained detectable in 25% of those with prior early Lyme disease and 62% of those with prior Lyme arthritis, including people without evidence of active infection.
• Therefore, IgG positivity documents prior immune recognition but cannot independently distinguish remote infection from current Lyme arthritis. CDC and IDSA/AAN/ACR guidance similarly note persistence for years to decades and advise against using antibodies to assess cure or treatment response.
• Active Lyme arthritis is a clinic-serologic diagnosis. The typical syndrome is objective swelling or effusion of one or a few large joints, commonly the knee, with validated two-tier serology and generally a broad Borrelia-specific IgG response. Pain without objective inflammatory findings is not sufficient.

Interpretation of negative IgM and PCR

• A negative IgM result does not reliably exclude late Lyme arthritis, which typically occurs after an established IgG response.
• Synovial-fluid PCR is an adjunctive rather than primary diagnostic test. Its reported pretreatment sensitivity ranges from approximately 40% to 96%; consequently, a negative PCR does not rule out active Lyme arthritis.
• Conversely, negative PCR and IgM do not make a positive IgG result diagnostic. They must be interpreted alongside examination findings and the broader differential diagnosis.

Mechanistic context

• Persistent IgG reflects durable immune recognition, not necessarily viable organisms, treatment failure, or protective immunity. Animal data suggest Borrelia may induce abnormal, short-lived germinal-center responses, but this does not establish the mechanism of persistent serology in an individual person.

Bottom line

• IgG-positive, IgM-negative, PCR-negative testing alone neither proves nor excludes active Lyme arthritis; objective compatible arthritis plus validated serology is central to diagnosis.